Interferon alpha 2b, Drugs Monitor

(14 May 2021) Interferon alpha 2b- associated with improved clinical outcomes in patients

May 27, 2021

Interferon-alpha-2b Aerosol Inhalation is Associated with Improved Clinical Outcomes in Patients with Coronavirus Disease-2019 https://doi.org/10.1111/bcp.14898 A total of 1401 patients were enrolled, 852 (60.8%) patients received 5,000,000 U of IFN-alpha-2b via aerosol inhalation twice daily. The primary outcome was a… Continue reading "(14 May 2021) Interferon alpha 2b- associated with improved clinical outcomes in patients"

(14 Mar 2021) PEG IFN-alpha2b- 80% subjects had a negative RT-PCR result on day 7

April 7, 2021

Efficacy and Safety of Pegylated Interferon alfa-2b in Moderate COVID-19: A phase II, randomized, controlled, open-label study https://doi.org/10.1016/j.ijid.2021.03.015 CTRI/2020/06/026087- In this phase 2, randomized, open-label study, adult subjects aged >18 years with RT-PCR confirmed COVID-19 with moderate symptoms were randomized… Continue reading "(14 Mar 2021) PEG IFN-alpha2b- 80% subjects had a negative RT-PCR result on day 7"

(04 August 2020) Interferons- Higher rate of recovery

August 6, 2020

Therapeutic effectiveness of interferon alpha 2b treatment for COVID-19 patient recovery https://doi.org/10.1101/2020.07.28.20157974.this A prospective observational study (RPCEC00000318) was implemented to monitor a therapeutic intervention with IFN alpha-2b used in the national protocol for COVID-19 attending in Cuba. Patients received therapy… Continue reading "(04 August 2020) Interferons- Higher rate of recovery"

Tag: Interferon alpha 2b

(14 May 2021) Interferon alpha 2b- associated with improved clinical outcomes in patients

(14 Mar 2021) PEG IFN-alpha2b- 80% subjects had a negative RT-PCR result on day 7

(04 August 2020) Interferons- Higher rate of recovery